Latest filing published 03 Nov 2023 for Century Therapeutics, Inc., €29k.
Insider track record
No signal scores available.
Michael Craig Diem: trading record in brief
Michael Craig Diem is a declared insider at 2 companies; the most frequent names are Century Therapeutics, Inc. and Nupathe Inc. The record holds 7 filings, for trades running from 11 August 2010 to 1 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 November 2023 with a share grant (€29k) in Century Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Craig Diem
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,763 shares@ US$1.49100.0% of flowCommon StockSEC:0001062993-23-020089:0
- 151,058 shares0Common StockSEC:0001062993-23-011401:0
- 21,875 shares0Common StockSEC:0001062993-23-002307:1
- 21,875 shares0Common StockSEC:0001062993-23-002307:0
- 242,568 shares@ US$10.00Common StockSEC:0001209191-10-042348:0
- 763,268 sharesCommon StockSEC:0001209191-10-042348:1
- 145,375 shares@ US$8.00Common StockSEC:0001209191-10-042348:2
7 of 7 declarations
